At least for the vaccine Cervarix, a randomized, control, double-blinded, prospective study has shown that it highly protects individuals from HPV 16 and 18 infection in the mouth/throat. The vaccine efficacy was calculated to be 93.3%. The big assumption being that reduced oral HPV 16/18 would lead to a decreased risk of throat cancer.
It is for these reasons that BOTH boys and girls are encouraged to get the HPV vaccine. We are talking about protecting our sons and daughters from getting throat and cervical CANCER later in life.
To be clear, more study is needed to really PROVE that such vaccines prevent throat cancer. For full disclosure, the weaknesses of this current study are as follows:
• It was performed only in women (the study would need to be replicated in males)
• The study lasted only 4 years... the question is whether life-long protection is present or will booster shots be needed?
• Does Gardasil also work for oral HPV 16/18?
• Does reduced HPV 16/18 presence in spit actually translate to decreased risk of throat cancer
• It is suspected that vaginal secretions carry a higher HPV viral load than the penis leading to a higher risk of throat cancer in men performing oral sex on infected women. As such, the other questions that need to be answered is whether such vaccines will:
• Prevent a vaccinated woman from giving HPV to the man as well as
• Prevent an infected woman to actually infect a vaccinated man?
• Or, does BOTH partners need to be vaccinated to prevent HPV throat cancer?
It is truly an exciting time when vaccines can be given to prevent not only infections like mumps or shingles, but also cancer!
Of note there are currently 3 FDA approved HPV vaccines:
• The bivalent HPV vaccine (Cervarix) which addresses HPV 16 and 18;
• The quadrivalent HPV vaccine (Gardasil) which prevents four HPV types: HPV 16 and 18, as well as HPV 6 and 11;
• And finally Gardasil 9 which prevents 9 HPV types: 6, 11, 16, 18, 31, 33, 45, 52, and 58.
Source:
HPV Vaccine Found to Help With Cancers of Throat. NYT 7/18/13
Reference:
Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PLOS One
Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States. J Clin Oncol. 2017 Nov 28:JCO2017750141. doi: 10.1200/JCO.2017.75.0141. [Epub ahead of print]
Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis. JAMA Otolaryngol Head Neck Surg. 2022;148(7):654-661. doi:10.1001/jamaoto.2022.1190.
1 comment:
I went through your Post came across to know the causes of throat cancer and how to prevent the disease,Its was nice to know that their are vacccine to prevent throat cancer.I would personally recommend people to go through these blogs and have an information,which would really help them in having some good ideas or knowledge about diseases and take an effective measure to overcome them.Thanks for sharing..
CLICK to Post a Comment